Higher adiponectin levels are linked to improved flow-mediated dilation and vascular health [34,35]; however, in chronic heart failure, strongly elevated levels may indicate resistance to adiponectin signaling and are associated with worse outcomes [34,36]. This evidence concerns the gene ADIPOQ and congestive heart failure.